Nigeria confirms first Ebola case in Abuja as health authorities activate response

First confirmed Ebola infection in the Federal Capital Territory The Federal Ministry of Health and Social Welfare announced that a woman who entered Nigeria on an international flight from Uganda has tested positive for Ebola virus disease. The patient was admitted to a private hospital in Abuja, where she received treatment for several days before laboratory confirmation on 20 October 2026. She is now being cared for in isolation, according to Minister of Health Prof. Muhammad Ali Pate.

Coordinated public‑health response Following the confirmation, the federal government activated an emergency public‑health response. The Ministry, together with the Nigeria Centre for Disease Control (NCDC), the FCT Health Services Secretariat and the Presidential Taskforce on Ebola Virus Disease, are overseeing containment efforts. Health officials have identified 44 individuals who had close contact with the patient, including healthcare workers, other patients, caregivers and anyone who may have shared travel links. Contact tracing has begun to determine any further exposure.

Recommendations from the medical community The Academy of Medical Sciences of Nigeria (AMSN) issued a statement expressing concern over the case while commending the swift isolation of the patient and the initiation of contact tracing. The academy urged the immediate implementation of high‑alert protocols across the country, drawing on the strategies that successfully limited the 2014 Ebola outbreak in Nigeria and the response to the COVID‑19 pandemic in 2020.

Regional context of the outbreak The Ebola strain involved is the Bundibugyo variant, which is circulating in Central and East Africa. The U.S. Centres for Disease Control and Prevention (CDC) reported that, as of 20 October 2026, the broader regional outbreak had resulted in 9,582 confirmed cases and 4,605 deaths across affected nations, including one death in Kenya and two in Uganda. The previous Ebola episode in the Democratic Republic of the Congo, declared over in December 2025, recorded 45 deaths from 64 confirmed or probable cases, reflecting a high case‑fatality rate.

No approved vaccine for the current strain Health authorities highlighted that the Bundibugyo strain does not yet have an approved vaccine or specific antiviral treatment, making early detection, isolation, supportive care and rigorous contact tracing essential to limiting transmission.

Government appeal to the public Minister Pate called on all public and private health facilities to remain on high alert, maintain strict infection‑prevention measures and report any suspected cases promptly. The government also appealed for calm, vigilance and cooperation from the public, stressing that early detection and swift reporting are critical to preventing further spread of the disease.

The situation remains under close monitoring, with regular updates expected from the Ministry and partner agencies as investigations continue.